Authors: Jandula, BM Nomdedeu, J Marin, P Vivancos, P

Citation: Bm. Jandula et al., Rituximab can be useful as treatment for minimal residual disease in bcr-abl-positive acute lymphoblastic leukemia, BONE MAR TR, 27(2), 2001, pp. 225-227

Authors: Brunet, S Urbano-Ispizua, A Ojeda, E Ruiz, D Moraleda, JM Diaz, MA Caballero, D Bargay, J de la Rubia, J Solano, C Zuazu, J Diez, JL de la Serna, J Espigado, I Alegre, A Torres, JP Jurado, M Fernandez, M Vivancos, P Carreras, E Hernandez, F Maldonado, J Sierra, J Rozman, C

Citation: S. Brunet et al., Favourable effect of the combination of acute and chronic graft-versus-host disease on the outcome of allogeneic peripheral blood stem cell transplantation for advanced haematological malignancies, BR J HAEM, 114(3), 2001, pp. 544-550

Authors: Vivancos, P Granena, A Sarra, J Granena, A

Citation: P. Vivancos et al., Treatment with interleukin-2 (IL-2) and interferon (IFNalpha 2b) after autologous bone marrow or peripheral blood stem cell transplantation in onco-hematological malignancies with a high risk of relapse, BONE MAR TR, 23(2), 1999, pp. 169-172